1. Home
  2. FOA vs VOR Comparison

FOA vs VOR Comparison

Compare FOA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOA
  • VOR
  • Stock Information
  • Founded
  • FOA 2013
  • VOR 2015
  • Country
  • FOA United States
  • VOR United States
  • Employees
  • FOA N/A
  • VOR N/A
  • Industry
  • FOA Finance Companies
  • VOR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOA Finance
  • VOR Health Care
  • Exchange
  • FOA Nasdaq
  • VOR Nasdaq
  • Market Cap
  • FOA 292.6M
  • VOR 261.0M
  • IPO Year
  • FOA N/A
  • VOR 2021
  • Fundamental
  • Price
  • FOA $27.80
  • VOR $1.96
  • Analyst Decision
  • FOA Buy
  • VOR Buy
  • Analyst Count
  • FOA 2
  • VOR 6
  • Target Price
  • FOA $27.50
  • VOR $3.90
  • AVG Volume (30 Days)
  • FOA 109.5K
  • VOR 5.2M
  • Earning Date
  • FOA 11-05-2025
  • VOR 11-06-2025
  • Dividend Yield
  • FOA N/A
  • VOR N/A
  • EPS Growth
  • FOA N/A
  • VOR N/A
  • EPS
  • FOA 7.10
  • VOR N/A
  • Revenue
  • FOA $527,520,999.00
  • VOR N/A
  • Revenue This Year
  • FOA $21.89
  • VOR N/A
  • Revenue Next Year
  • FOA $10.33
  • VOR N/A
  • P/E Ratio
  • FOA $3.88
  • VOR N/A
  • Revenue Growth
  • FOA 46.94
  • VOR N/A
  • 52 Week Low
  • FOA $8.69
  • VOR $0.13
  • 52 Week High
  • FOA $32.40
  • VOR $3.29
  • Technical
  • Relative Strength Index (RSI)
  • FOA 58.57
  • VOR 47.83
  • Support Level
  • FOA $25.45
  • VOR $2.05
  • Resistance Level
  • FOA $26.80
  • VOR $2.11
  • Average True Range (ATR)
  • FOA 1.24
  • VOR 0.16
  • MACD
  • FOA -0.10
  • VOR -0.03
  • Stochastic Oscillator
  • FOA 66.20
  • VOR 9.84

About FOA Finance of America Companies Inc.

Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Share on Social Networks: